Bilateral Scleritis and Choroidal Infarction in a Postpartum Patient with Antiphospholipid Syndrome
Journal of Current Ophthalmology · 03.08.2026
DOI: 10.4103/joco.joco_49_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Current Ophthalmology, online erschienen am 03.08.2026. Verfasst von Nicholas Strobl und 3 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Purpose
To report a postpartum case of antiphospholipid syndrome (APS) presenting with bilateral scleritis and choroidal infarction.
Methods
The patient underwent a comprehensive ophthalmic examination and multimodal imaging.
Results
A 32-year-old female presented 3 days postpartum with bilateral anterior scleritis, left-sided posterior scleritis, and bilateral choroidal infarcts. Systemic workup revealed elevated cardiolipin and beta-2 glycoprotein I antibodies, leading to a diagnosis of primary APS. Treatment with corticosteroids and anticoagulation resulted in significant visual improvement and anatomical reconstruction of the ellipsoid zone.
Conclusions
Patients with postpartum APS can present with atypical ocular inflammation. Early recognition is essential for prompt systemic evaluation and treatment to support visual recovery.
Zitieren
APA
Strobl, N., George, B., Garner, C., & Guner, M. K. (2026). Bilateral Scleritis and Choroidal Infarction in a Postpartum Patient with Antiphospholipid Syndrome. Journal of Current Ophthalmology. https://doi.org/10.4103/joco.joco_49_26
Vancouver
Strobl N, George B, Garner C, Guner MK. Bilateral Scleritis and Choroidal Infarction in a Postpartum Patient with Antiphospholipid Syndrome. Journal of Current Ophthalmology. 2026. doi:10.4103/joco.joco_49_26
BibTeX
@article{Strobl2026,
author = {Strobl, Nicholas and George, Bria and Garner, Cameron and Guner, Melis Kabaalioglu},
title = {Bilateral Scleritis and Choroidal Infarction in a Postpartum Patient with Antiphospholipid Syndrome},
journal = {Journal of Current Ophthalmology},
year = {2026},
doi = {10.4103/joco.joco_49_26}
}
EUVIMED